Detalle Publicación

ARTÍCULO

Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p. Ser43Asn mutation in the TTR gene

Autores: Montero Calle, Maria del Pilar; Flandes Iparraguirre, María; Kuebler, B.; Arán, B.; Larequi Ardanáz, Eduardo; Anaut, I.; Coppiello, Giulia; Aranguren López, Xabier; Veiga, A.; Basuarte Elorz, M. T.; García de Yébenes Castro, Manuel; Gavira Gómez, Juan José; Prosper Cardoso, Felipe; Iglesias García, Olalla (Autor de correspondencia); Mazo Vega, Manuel María (Autor de correspondencia)
Título de la revista: STEM CELL RESEARCH
ISSN: 1873-5061
Volumen: 71
Páginas: 103189
Fecha de publicación: 2023
Resumen:
Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a life-threatening disease caused by the abnormal production of misfolded TTR protein by liver cells, which is then released systemically. Its amyloid deposition in the heart is linked to cardiac toxicity and progression toward heart failure. A human induced pluripotent stem cell (iPSC) line was generated from peripheral blood mononuclear cells (PBMCs) from a patient suffering familial transthyretin amyloid cardio-myopathy carrying a c.128G>A (p.Ser43Asn) mutation in the TTR gene. This iPSC line offers a useful resource to study the disease pathophysiology and a cell-based model for therapeutic discovery.
Enlace DADUN: https://dadun.unav.edu/handle/10171/67879
DOI: https://doi.org/10.1016/j.scr.2023.103189
Impacto:
Google Scholar